PEREGRINE PHARMACEUTICALS IN's ticker is and the CUSIP is 713661904. A total of 2 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $8,000 | +100.0% | 13,300 | +111.1% | 0.00% | – |
| Q1 2017 | $4,000 | – | 6,300 | +800.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 700 | -96.7% | 0.00% | – |
| Q2 2016 | $8,000 | -87.7% | 21,000 | -86.3% | 0.00% | -100.0% |
| Q1 2016 | $65,000 | +12.1% | 153,500 | +208.2% | 0.00% | 0.0% |
| Q4 2015 | $58,000 | +70.6% | 49,800 | +50.9% | 0.00% | – |
| Q3 2015 | $34,000 | -59.5% | 33,000 | -48.5% | 0.00% | -100.0% |
| Q2 2015 | $84,000 | +10.5% | 64,100 | +14.1% | 0.00% | 0.0% |
| Q1 2015 | $76,000 | -53.4% | 56,200 | -52.2% | 0.00% | -50.0% |
| Q4 2014 | $163,000 | -51.9% | 117,600 | -52.9% | 0.00% | -60.0% |
| Q3 2014 | $339,000 | +57.7% | 249,600 | +118.0% | 0.01% | +66.7% |
| Q2 2014 | $215,000 | -58.7% | 114,500 | -58.2% | 0.00% | -66.7% |
| Q1 2014 | $520,000 | +1081.8% | 273,600 | +760.4% | 0.01% | +800.0% |
| Q4 2013 | $44,000 | -85.8% | 31,800 | -85.5% | 0.00% | -83.3% |
| Q3 2013 | $309,000 | -47.7% | 218,900 | -52.2% | 0.01% | -60.0% |
| Q2 2013 | $591,000 | – | 457,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 31,800 | $44,000 | 0.00% |
| Citadel Advisors | 2,700 | $4,000 | 0.00% |